Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Endosc Int Open ; 11(10): E952-E962, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37828974

ABSTRACT

Background and study aims For non-dysplastic Barrett's Esophagus (BE) patients, guidelines recommend endoscopic surveillance every 3 to 5 years with four-quadrant random biopsies every 2 cm of BE length. Adherence to these guidelines is low in clinical practice. Pooling BE surveillance endoscopies on dedicated endoscopy lists performed by dedicated endoscopists could possibly enhance guideline adherence, detection of visible lesions, and dysplasia detection rates (DDRs). Patients and methods Data were used from the ACID-study (Netherlands Trial Registry NL8214), a prospective trial of BE surveillance in the Netherlands. BE patients with known or previously treated dysplasia were excluded. Guideline adherence, detection of visible lesions, and DDRs were compared for patients on dedicated and general endoscopy lists. Results A total of 1,244 patients were included, 318 on dedicated lists and 926 on general lists. Endoscopies on dedicated lists showed significantly higher adherence to the random biopsy protocol (85% vs. 66%, P <0.01) and recommended surveillance intervals (60% vs. 47%, P <0.01) compared to general lists. Detection of visible lesions (8.8% vs. 8.1%, P =0.79) and DDRs were not significantly different (6.9% and 6.6%, P =0.94). None (0.0%) of the patients scheduled on dedicated lists and 10 (1.1%) on general lists were diagnosed with esophageal adenocarcinoma ( P =0.07). In multivariable analysis, dedicated lists were significantly associated with biopsy protocol adherence and adherence to surveillance interval recommendations with odds ratios of 4.45 (95% confidence interval [CI] 2.07-9.57) and 1.64 (95% CI 1.03-2.61), respectively. Conclusions Dedicated endoscopy lists are associated with better adherence to the random biopsy protocol and surveillance interval recommendations.

2.
Gut ; 64(6): 864-71, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25037191

ABSTRACT

OBJECTIVE: Surveillance is recommended for Barrett's oesophagus (BO) to detect early oesophageal adenocarcinoma (OAC). The aim of this study was to evaluate the cost-effectiveness of surveillance. DESIGN: We included 714 patients with long-segment BO in a multicentre prospective cohort study and used a multistate Markov model to calculate progression rates from no dysplasia (ND) to low-grade dysplasia (LGD), high-grade dysplasia (HGD) and OAC. Progression rates were incorporated in a decision-analytic model, including costs and quality of life data. We evaluated different surveillance intervals for ND and LGD, endoscopic mucosal resection (EMR), radiofrequency ablation (RFA) and oesophagectomy for HGD or early OAC and oesophagectomy for advanced OAC. The incremental cost-effectiveness ratio (ICER) was calculated in costs per quality-adjusted life-year (QALY). RESULTS: The annual progression rate was 2% for ND to LGD, 4% for LGD to HGD or early OAC and 25% for HGD or early OAC to advanced OAC. Surveillance every 5 or 4 years with RFA for HGD or early OAC and oesophagectomy for advanced OAC had ICERs of €5.283 and €62.619 per QALY for ND. Surveillance every five to one year had ICERs of €4.922, €30.067, €32.531, €41.499 and €75.601 per QALY for LGD. EMR prior to RFA was slightly more expensive, but important for tumour staging. CONCLUSIONS: Based on a Dutch healthcare perspective and assuming a willingness-to-pay threshold of €35.000 per QALY, surveillance with EMR and RFA for HGD or early OAC, and oesophagectomy for advanced OAC is cost-effective every 5 years for ND and every 3 years for LGD.


Subject(s)
Adenocarcinoma/pathology , Barrett Esophagus/pathology , Esophageal Neoplasms/pathology , Esophagoscopy/economics , Precancerous Conditions/pathology , Adenocarcinoma/epidemiology , Adenocarcinoma/surgery , Barrett Esophagus/epidemiology , Barrett Esophagus/psychology , Catheter Ablation/economics , Causality , Cohort Studies , Cost-Benefit Analysis , Disease Progression , Early Diagnosis , Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/surgery , Esophagectomy/economics , Female , Follow-Up Studies , Humans , Incidence , Male , Markov Chains , Middle Aged , Neoplasm Staging , Population Surveillance/methods , Precancerous Conditions/epidemiology , Precancerous Conditions/surgery , Prospective Studies , Quality of Life
3.
Am J Gastroenterol ; 106(7): 1231-8, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21577245

ABSTRACT

OBJECTIVES: Patients with Barrett's esophagus (BE) have an increased risk of developing esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for predictors of neoplastic progression to tailor more individualized surveillance programs. The aim of this study was to identify such predictors of progression to high-grade dysplasia (HGD) and EAC in patients with BE after 4 years of surveillance and to develop a prediction model based on these factors. METHODS: We included 713 patients with BE (≥ 2 cm) with no dysplasia (ND) or low-grade dysplasia (LGD) in a multicenter, prospective cohort study. Data on age, gender, body mass index (BMI), reflux symptoms, tobacco and alcohol use, medication use, upper gastrointestinal (GI) endoscopy findings, and histology were prospectively collected. As part of this study, patients with ND underwent surveillance every 2 years, whereas those with LGD were followed on a yearly basis. Log linear regression analysis was performed to identify risk factors associated with the development of HGD or EAC during surveillance. RESULTS: After 4 years of follow-up, 26/713 (3.4%) patients developed HGD or EAC, with the remaining 687 patients remaining stable with ND or LGD. Multivariable analysis showed that a known duration of BE of ≥ 10 years (risk ratio (RR) 3.2; 95% confidence interval (CI) 1.3-7.8), length of BE (RR 1.11 per cm increase in length; 95% CI 1.01-1.2), esophagitis (RR 3.5; 95% CI 1.3-9.5), and LGD (RR 9.7; 95% CI 4.4-21.5) were significant predictors of progression to HGD or EAC. In a prediction model, we found that the annual risk of developing HGD or EAC in BE varied between 0.3% and up to 40%. Patients with ND and no other risk factors had the lowest risk of developing HGD or EAC (<1%), whereas those with LGD and at least one other risk factor had the highest risk of neoplastic progression (18-40%). CONCLUSIONS: In patients with BE, the risk of developing HGD or EAC is predominantly determined by the presence of LGD, a known duration of BE of ≥10 years, longer length of BE, and presence of esophagitis. One or combinations of these risk factors are able to identify patients with a low or high risk of neoplastic progression and could therefore be used to individualize surveillance intervals in BE.


Subject(s)
Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Barrett Esophagus/pathology , Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/pathology , Precancerous Conditions/pathology , Adult , Aged , Aged, 80 and over , Esophagitis/pathology , Female , Humans , Linear Models , Male , Middle Aged , Prospective Studies , Risk Factors , Time Factors , Watchful Waiting , Young Adult
4.
J Clin Monit ; 11(4): 237-44, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7561997

ABSTRACT

In this study, we investigated the possibility of improving reflectance (back-scatter) pulse oximetry measurements by pressure applied to the probe. Optimal signal detection, with the probe applied to an easily accessible location, is important to prevent erroneous oxygen saturation readouts. At the foreheads of 10 healthy adult volunteers, the effects of pressure applied onto the reflectance pulse oximeter probe were studied. Distances between the LEDs (660 nm and 940 nm) and the three photodiodes in the sensor were 4 mm, 7 mm, and 10 mm. For each detector, recordings were evaluated regarding red-to-infrared (R/IR) ratios and pulse sizes in relation to the stepwise increased pressure applied to the probe. R/IR variability decreased with applied pressures between 60 and 120 mm Hg. These findings are partly attributed to a corresponding increase in red and infrared pulse sizes at the detectors, which results in an improved signal-to-noise ratio. It is thought that pressure onto the oximeter sensor forces venous blood out of the tissues underneath the sensor. Consequently, the disturbing influence of pulsating and non-pulsating venous blood is reduced. Moreover, the increased difference in vessel diameter between diastole and systole and the corresponding difference in light absorption and an increase in flow velocities, causes an increase in pulse size with increasing pressure on the probe. Pressure applied to the probe may be useful in increasing the accuracy of reflectance pulse oximetry.


Subject(s)
Oximetry/methods , Adult , Calibration , Equipment Design , Female , Fetal Monitoring/instrumentation , Forehead , Humans , Male , Oximetry/instrumentation , Pressure
SELECTION OF CITATIONS
SEARCH DETAIL
...